W.E.M. Kok MD PhD publications

2021

• Kok Wouter E. Too often and too early: The risk of cardiac ischaemia in adult survivors of childhood cancer Heart (British Cardiac Society) 2021;107 (1):6-7 [PubMed]

2020

• Leerink Jan M., Feijen E. Lieke A. M., van der Pal Helena J. H., Kok Wouter E. M., Mavinkurve-Groothuis Annelies M. C., Kapusta Livia, Pinto Yigal M., Maas Angela H. E. M., Bellersen Louise, Teske Arco J., Ronckers Cécile M., Louwerens Marloes, van Dalen Elvira C., van Dulmen-den Broeder Eline, Batenburg Lilian, van der Heiden-van der Loo Margriet, van den Heuvel-Eibrink Marry M., van Leeuwen Flora E., de Vries Andrica C. H., Weijers Gert, de Korte Chris L., Loonen Jacqueline J., Neggers Sebastian J. C. M. M., Versluys A. B. Birgitta, Tissing Wim J. E., Kremer Leontien C. M. Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study American heart journal 2020;219:89-98 [PubMed]
• Wierda Eric, Dickhoff Cathelijne, Handoko Martin Louis, Oosterom Liane, Kok Wouter Emmanuel, de Rover Y., de Mol B. A. J. M., van Heerebeek Loek, Schroeder-Tanka Jutta Maria Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature ESC heart failure 2020;7 (3):892-902 [PubMed]
• van de Bovenkamp A. A., Bakermans A. J., Allaart C. P., Nederveen A. J., Kok W. E. M., van Rossum A. C., Handoko M. L. TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study Netherlands heart journal 2020;28 (6):312-319 [PubMed]
• van der Zande Julia M. J., Baarsma M. E., Grundeken Maik J., Verhaar Nienke, Kok Wouter E. M., Hovius Joppe W. Tweedegraads atrioventriculair blok door lymeziekte Nederlands tijdschrift voor geneeskunde 2020;164 (7)

2019

• Brugts J. J., Veenis J. F., Radhoe S. P., Linssen G. C. M., van Gent M., Borleffs C. J. W., van Ramshorst J., van Pol P., Tukkie R., Spee R. F., Emans M. E., Kok W., van Halm V., Handoko L., Beeres S. L. M. A., Post M. C., Boersma E., Lenzen M. J., Manintveld O. C., Koffijberg H., van Baal P., Versteegh M., Smilde T. D., van Heerebeek L., Rienstra M., Mosterd A., Delnoy P. P. H., Asselbergs F. W., Brunner-la Rocca H. P., de Boer R. A. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial Netherlands heart journal 2019;28 (1):16-26 [PubMed]
• Leerink Jan M., Verkleij Simone J., Feijen Elizabeth A. M., Mavinkurve-Groothuis Annelies M. C., Pourier Milanthy S., Ylänen Kaisa, Tissing Wim J. E., Louwerens Marloes, van den Heuvel Marry M., van Dulmen-den Broeder Eline, de Vries Andrica C. H., Ronckers Cecile M., van der Pal Heleen J. H., Kapusta Livia, Loonen Jacqueline, Bellersen Louise, Pinto Yigal M., Kremer Leontien C. M., Kok Wouter E. M. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: A systematic review Heart (British Cardiac Society) 2019;105 (3):210-216 [PubMed]
• Aalders Margot, Kok Wouter Comparison of Hemodynamic Factors Predicting Prognosis in Heart Failure: A Systematic Review Journal of clinical medicine 2019;8 (10) [PubMed]
• Salah Khibar, Stienen Susan, Moons Andreas H. M., Bakx Adrianus L. M., van Pol Petra E., Kortz R. A. Mikael, Ferreira João Pedro, Marques Irene, Schroeder-Tanka Jutta M., Keijer Jan T., Bayes-Genis Antoni, Pinto Yigal M., Tijssen Jan G., Kok Wouter E. External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure Journal of the American Heart Association 2019;8 (14):e010309 [PubMed]
• Salah Khibar, Stienen Susan, Pinto Yigal M., Eurlings Luc W., Metra Marco, Bayes-Genis Antoni, Verdiani Valerio, Tijssen Jan G. P., Kok Wouter E. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction Heart (British Cardiac Society) 2019;105 (15):1182-1189 [PubMed]
• Feijen E. A. M. Lieke, Font-Gonzalez Anna, van der Pal Helena J. H., Kok Wouter E. M., Geskus Ronald B., Ronckers C. cile M., Bresters Dorine, van Dalen Elvira C., van Dulmen-den Broeder Eline, van den Berg Marleen H., van der Heiden-van der Loo Margriet, van den Heuvel-Eibrink Marry M., van Leeuwen Flora E., Loonen Jacqueline J., Neggers Sebastian J. C. M. M., Versluys A. B. Birgitta, Tissing Wim J. E., Kremer Leontien C. M. Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study Journal of the American Heart Association 2019;8 (1):e009122 [PubMed]

2018

• Staartjes Victor E., Schillevoort Shiva A., Blum Patricia G., van Tintelen J. Peter, Kok Wouter E., Schröder Marc L. Cardiac Arrest During Spine Surgery in the Prone Position: Case Report and Review of the Literature World neurosurgery 2018;115:460-467.e1 [PubMed]
• van Dijk Irma W. E. M., Visser Jorrit, Wiersma Jan, van Boggelen Jessica R., Balgobind Brian V., Feijen Elizabeth A. M. (Lieke), Huijskens Sophie C., Kok Wouter E. M., Kremer Leontien C. M., Rasch Coen R. N., Bel Arjan Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon Radiotherapy and oncology 2018;128 (2):214-220 [PubMed]
• de Vries Simone, Schaapveld Michael, van Nimwegen Frederika A., Jóźwiak Katarzyna, Lugtenburg Pieternella J., Daniëls Laurien A., Roesink Judith M., van der Maazen Richard W. M., Kok Wouter E. M., Aleman Berthe M. P., van Leeuwen Flora E. High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors British journal of cancer 2018;118 (6):887-895 [PubMed]
• Salah Khibar NT-proBNP as a risk stratification tool for the management of acute decompensated heart failure 2018. ISBN 9789463611695. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Pinto Y. M.; Co-supervisors: Kok W. E. M., Tijssen J. G. P.)
• Stienen Susan NT-proBNP-guided therapy in acute decompensated heart failure 2018. ISBN 9789463610551. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Pinto Y. M.; Co-supervisor: Kok W. E. M.)
• Stienen Susan, Salah Khibar, Moons Arno H., Bakx Adrianus L., van Pol Petra, Kortz Mikael, Ferreira João Pedro, Marques Irene, Schroeder-Tanka Jutta M., Keijer Jan T., Bayés-Genis Antoni, Tijssen Jan G. P., Pinto Yigal M., Kok Wouter E. NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial Circulation 2018;137 (16):1671–1683 [PubMed]
• Kok Wouter, Stienen Susan Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)" Circulation 2018;138 (17):1910-1911 [PubMed]
• Kok Wouter, Salah Khibar, Stienen Susan Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure: Identifying Possible Threats to Outcome American journal of cardiology 2018;121 (1):141 [PubMed]

2017

• Kwakman Johannes J. M., Baars Arnold, van Zweeden Annette A., de Mol Pieter, Koopman Miriam, Kok Wouter E. M., Punt Cornelis J. A. Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm European journal of cancer (Oxford, England 2017;81:130-134 [PubMed]
• Kok Wouter E. Editorial commentary: Biomarkers in heart failure, between scientific scrutiny and exploration Trends in cardiovascular medicine 2017;27 (2):134-135 [PubMed]
• Kwakman Johannes J. M., Simkens Lieke H. J., Mol Linda, Kok Wouter E. M., Koopman Miriam, Punt Cornelis J. A. Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group European journal of cancer (Oxford, England 2017;76:93-99 [PubMed]

2016

• Kok Wouter E. M. Contra-indicaties: Hartfalenin: S. D. Borgsteede, C. G. Colijn, V. M. Eimermann, S. W. G. Neutkens, Kayan Tsoi, editors. Commentaren Medicatiebewaking 2016/2017. Houten: Health Base; 2016. p. 825-835, ISBN 9789074027397
• Kok Wouter E. M., Meijer Karina Contra-indicaties: Ischemische hartziekten, inclusief angina pectorisin: S. D. Borgsteede, C. G. Colijn, V. M. Eimermann, S. W. G. Neutkens, Kayan Tsoi, editors. Commentaren Medicatiebewaking 2016/2017. Houten: Health Base; 2016. p. 805-817, ISBN 9789074027397
• Salah Khibar, Kok Wouter E., Pinto Yigal M. Reply: Worsening Renal Function in Acute Decompensated Heart Failure: The Puzzle is Still Incomplete JACC. Heart failure 2016;4 (3):233-234 [PubMed]
• Stienen Susan, Salah Khibar, Eurlings Luc W., Bettencourt Paulo, Pimenta Joana M., Metra Marco, Bayes-Genis Antoni, Verdiani Valerio, Bettari Luca, Lazzarini Valentina, Tijssen Jan P., Pinto Yigal M., Kok Wouter E. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients JACC. Heart failure 2016;4 (9):736-745 [PubMed]

2015

• van Nimwegen Frederika A., Schaapveld Michael, Janus Cécile P. M., Krol Augustinus D. G., Petersen Eefke J., Raemaekers John M. M., Kok Wouter E. M., Aleman Berthe M. P., van Leeuwen Flora E. Cardiovascular disease after hodgkin lymphoma treatment: 40-year disease risk JAMA internal medicine 2015;175 (6):1007-1017 [PubMed]
• Stienen Susan, Salah Khibar, Eurlings Luc W. M., Bettencourt Paulo, Pimenta Joana M., Metra Marco, Bayes-Genis Antoni, Verdiani Valerio, Bettari Luca, Lazzarini Valentina, Tijssen Jan P., Pinto Yigal M., Kok Wouter E. M. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? European journal of heart failure 2015;17 (9):936-944 [PubMed]
• Salah Khibar, Kok Wouter E., Eurlings Luc W., Bettencourt Paulo, Pimenta Joana M., Metra Marco, Verdiani Valerio, Tijssen Jan G., Pinto Yigal M. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure JACC. Heart failure 2015;3 (10):751-761 [PubMed]
• Kok Wouter E. M. Contra-Indicaties - Angina pectorisin: S. D. Borgsteede, C. G. Colijn, V. M. Eimermann, M. Heringa, S. W. G. Neutkens, Kayan Tsoi, editors. Commentaren Medicatiebewaking 2015/2016. Houten: Health Base; 2015. p. 814-821, ISBN 9789074027380
• Kok Wouter E. M. Contra-Indicaties - Hartfalenin: S. D. Borgsteede, C. G. Colijn, V. M. Eimermann, M. Heringa, S. W. G. Neutkens, Kayan Tsoi, editors. Commentaren Medicatiebewaking 2015/2016. Houten: Health Base; 2015. p. 829-839, ISBN 9789074027380
• Smid B. E., Hollak C. E. M., Poorthuis B. J. H. M., van den Bergh Weerman M. A., Florquin S., Kok W. E. M., Lekanne Deprez R. H., Timmermans J., Linthorst G. E. Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance Clinical genetics 2015;88 (2):161-166 [PubMed]
• Stienen Susan, Salah Khibar, Dickhoff Cathelijne, Carubelli Valentina, Metra Marco, Magrini Laura, Di Somma Salvatore, Tijssen Jan P., Pinto Yigal M., Kok Wouter E. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment Journal of cardiac failure 2015;21 (11):930-934 [PubMed]
• Visser Marlieke, Niessen Hans W. M., Kok Wouter E. M., Cocchieri Riccardo, Wisselink Willem, van Leeuwen Paul A. M., de Mol Bas A. J. M. Nutrition before and during Surgery and the Inflammatory Response of the Heart: A Randomized Controlled Trial Journal of nutrition and metabolism 2015;2015:123158 [PubMed]
• Stienen Susan, Kok Wouter E. M. Response to: Letter to the editor regarding the manuscript "Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes" American heart journal 2015;169 (4):e5 [PubMed]
• Salah Khibar, Pinto Yigal M., Eurlings Luc W., Metra Marco, Stienen Susan, Lombardi Carlo, Tijssen Jan G., Kok Wouter E. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis American heart journal 2015;170 (3):531-42.e1 [PubMed]
• van der Pal Helena J., van Dijk Irma W., Geskus Ronald B., Kok Wouter E., Koolen Marianne, Sieswerda Elske, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Caron Huib N., Kremer Leontien C., van Dalen Elvira C. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study International journal of radiation oncology, biology, physics 2015;91 (1):213-222 [PubMed]

2014

• Salah Khibar, Kok Wouter E., Eurlings Luc W., Bettencourt Paulo, Pimenta Joana M., Metra Marco, Bayes-Genis Antoni, Verdiani Valerio, Bettari Luca, Lazzarini Valentina, Damman Peter, Tijssen Jan G., Pinto Yigal M. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score Heart (British Cardiac Society) 2014;100 (2):115-125 [PubMed]
• Kok Wouter E. M. Contra-Indicaties - angina pectorisin: Sander D. Borgsteede, C. G. Colijn, V. M. Eimermann, J. J. de Gier, J. S. Lagas, M. Heringa, J. C. Klaucke, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2014/2015. Houten: Health Base; 2014. p. 769-775, ISBN 9789074027366
• Kok Wouter E. M. Contra-Indicaties - Hartfalenin: Sander D. Borgsteede, C. G. Colijn, V. M. Eimermann, J. J. de Gier, J. S. Lagas, M. Heringa, J. C. Klaucke, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2014/2015. Houten: Health Base; 2014. p. 783-792, ISBN 9789074027366
• Visser Marlieke, Davids Mariska, Verberne Hein J., Kok Wouter E. M., Tepaske Robert, Cocchieri Riccardo, Kemper Elles M., Teerlink Tom, Jonker Marianne A., Wisselink Willem, de Mol Bas A. J. M., van Leeuwen Paul A. M. Nutrition before, during, and after surgery increases the arginine:asymmetric dimethylarginine ratio and relates to improved myocardial glucose metabolism: a randomized controlled trial American journal of clinical nutrition 2014;99 (6):1440-1449 [PubMed]
• Stienen Susan, Salah Khibar, Moons Andreas H. M., Bakx Adrianus L. M., van Pol Petra E., Schroeder-Tanka Jutta M., Voogel Albertus J., Keijer Jan T., Kortz R. A. Mikael, Dickhoff Cathelijne, Meregalli Paola G., Tijssen Jan G., Pinto Yigal M., Kok Wouter E. Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes American heart journal 2014;168 (1):30-36 [PubMed]

2013

• Kok Wouter E. M. Angina pectorisin: C. G. Colijn, V. M. Eimermann, J. J. de Gier, J. Hartman, M. Heringa, J. C. Klaucke, H. Mulder, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2013/2014. Houten: Health Base; 2013. p. 741-745, ISBN 9789074027359
• de Peuter Olav R., Verberne Hein J., Kok Wouter E., van den Bogaard Bas, Schaap Marianna C., Nieuwland Rienk, Meijers Joost C. M., Somsen G. Aernout, Bakx Ad, Kamphuisen Pieter W. Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure Journal of nuclear medicine 2013;54 (10):1733-1739 [PubMed]
• Kok Wouter E. M. Hartfalenin: C. G. Colijn, V. M. Eimermann, J. J. de Gier, J. Hartman, M. Heringa, J. C. Klaucke, H. Mulder, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2013/2014. Houten: Health Base; 2013. p. 753-761, ISBN 9789074027359

2012

• Kok Wouter E. M. Angina pectorisin: H. C. S. van Buren, C. G. Colijn, V. M. Eimermann, J. J. de Gier, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2012/2013. Houten: Boekbinderij Van Hees, Zaltbommel; 2012. p. 700-704, ISBN 9789074027007
• Kok Wouter E. M. Hartfalenin: H. C. S. van Buren, C. G. Colijn, V. M. Eimermann, J. J. de Gier, S. W. G. Neutkens, editors. Commentaren Medicatiebewaking 2012/2013. Houten: Boekbinderij Van Hees, Zaltbommel; 2012. p. 711-718, ISBN 9789074027007
• van der Pal Helena J., van Dalen Elvira C., van Delden Evelien, van Dijk Irma W., Kok Wouter E., Geskus Ronald B., Sieswerda Elske, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Caron Huib N., Kremer Leontien C. High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors Journal of clinical oncology 2012;30 (13):1429-1437 [PubMed]
• Sieswerda E., Postma A., van Dalen E. C., van der Pal H. J. H., Tissing W. J. E., Rammeloo L. A. J., Kok W. E. M., van Leeuwen F. E., Caron H. N., Kremer L. C. M. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors Annals of oncology 2012;23 (8):2191-2198 [PubMed]

2011

• van der Pal Helena J., van Dalen Elvira C., Hauptmann Michael, Kok Wouter E., Caron Huib N., van den Bos Cor, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Kremer Leontien C. Cardiac Function in 5-Year Survivors of Childhood Cancer Reply Archives of internal medicine 2011;171 (3):264-265
• van Rijsingen I. A. W., Pinto Y. M., Kok W. E. M. Onduidelijkheden in de diagnostiek van hartfalen Nederlands tijdschrift voor geneeskunde 2011;155 (10):A3159 [PubMed]
• Visser Marlieke, Davids Mariska, Verberne Hein J., Kok Wouter E. M., Niessen Hans W. M., van Venrooij Lenny M. W., Cocchieri Riccardo, Wisselink Willem, de Mol Bas A. J. M., van Leeuwen Paul A. M. Rationale and design of a proof-of-concept trial investigating the effect of uninterrupted perioperative (par)enteral nutrition on amino acid profile, cardiomyocytes structure, and cardiac perfusion and metabolism of patients undergoing coronary artery bypass grafting Journal of cardiothoracic surgery 2011;6 (1):36 [PubMed]
• Truijen Jasper, de Peuter Olav R., Kim Yu-Sok, van den Bogaard Bas, Kok Wouter E., Kamphuisen Pieter W., van Lieshout Johannes J. β2-adrenergic receptor genotype influences the effect of nonselective vs. selective β-blockade on baroreflex function in chronic heart failure International journal of cardiology 2011;153 (2):230-232 [PubMed]

2010

• Kok Wouter E. M. Angina pectorisin: J. J. de Gier, H. C. S. van Buren, V. M. Eimermann, M. Heringa, C. B. Koekoek, M. C. Star, editors. Commentaren Medicatiebewaking 2010/2011. Houten: Boekbinderij Van Hees, Zaltbommel; 2010. p. 612-616, ISBN 9789074027311
• van der Pal Helena J., van Dalen Elvira C., Hauptmann Michael, Kok Wouter E., Caron Huib N., van den Bos Cor, Oldenburger Foppe, Koning Caro C., van Leeuwen Flora E., Kremer Leontien C. Cardiac Function in 5-Year Survivors of Childhood Cancer A Long-term Follow-up Study Archives of internal medicine 2010;170 (14):1247-1255 [PubMed]
• Kok Wouter E. M. Hartfalenin: J. J. de Gier, H. C. S. van Buren, V. M. Eimermann, M. Heringa, C. B. Koekoek, M. C. Star, editors. Commentaren Medicatiebewaking 2010/2011. Houten: Boekbinderij Van Hees, Zaltbommel; 2010. p. 623-630, ISBN 9789074027311
• Eurlings Luc W. M., van Pol Petra E. J., Kok Wouter E., van Wijk Sandra, Lodewijks-van der Bolt Cara, Balk Aggie H. M. M., Lok Dirk J. A., Crijns Harry J. G. M., van Kraaij Dave J. W., de Jonge Nicolaas, Meeder Joan G., Prins Martin, Pinto Yigal M. Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study Journal of the American College of Cardiology 2010;56 (25):2090-2100 [PubMed]
• Tijsen Anke J., Creemers Esther E., Moerland Perry D., de Windt Leon J., van der Wal Allard C., Kok Wouter E., Pinto Yigal M. MiR423-5p As a Circulating Biomarker for Heart Failure Circulation research 2010;106 (6):1035-U63 [PubMed]

2009

• Kok Wouter E. M. Angina pectorisin: H. C. S. van Buren, J. J. de Gier, editors. Commentaren Medicatiebewaking 2009/2010. Houten: Health Base; 2009. p. 721-726, ISBN 9789074027304
• Kok Wouter E. M. Hartfalenin: H. C. S. van Buren, J. J. de Gier, editors. Commentaren Medicatiebewaking 2009/2010. Houten: Health Base; 2009. p. 734-742, ISBN 9789074027304
• de Peuter Olav R., Kok Wouter E. M., Torp-Pedersen Christian, Büller Harry R., Kamphuisen Pieter W. Systolic Heart Failure: A Prothrombotic State Seminars in thrombosis and hemostasis 2009;35 (5):497-504 [PubMed]

2008

• Meregalli P. G., Westendorp I. C. D., Tan H. L., Elsman P., Kok W. E. M., Wilde A. A. M. Pregnancy and the risk of torsades de pointes in congenital long-QT syndrome Netherlands heart journal 2008;16 (12):422-425 [PubMed]
• Sankatsing S. U. C., Hanselaar W. E. J. J., van Steenwijk R. P., Van der Sloot J. A. P., Broekhuis E., Kok W. E. M. Recurrent acute pulmonary oedema after aortic and mitral valve surgery due to trachea malacia and obstructive sleep apnoea syndrome Netherlands heart journal 2008;16 (9):310-312 [PubMed]

2006

• van Dalen Elvira C., van der Pal Helena J. H., van den Bos Cor, Kok Wouter E. M., Caron Huib N., Kremer Leontien C. M. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines European journal of cancer (Oxford, England 2006;42 (15):2549-2553 [PubMed]
• van Dalen Elvira C., van der Pal Helena J. H., Kok Wouter E. M., Caron Huib N., Kremer Leontien C. M. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study European journal of cancer (Oxford, England 2006;42 (18):3191-3198 [PubMed]
• Knaapen Paul, van Dockum Willem G., Götte Marco J. W., Broeze Kimiko A., Kuijer Joost P. A., Zwanenburg Jaco J. M., Marcus J. Tim, Kok Wouter E. M., van Rossum Albert C., Lammertsma Adriaan A., Visser Frans C. Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study Journal of nuclear cardiology 2006;13 (5):660-667 [PubMed]

2005

• Knaapen Paul, van Dockum Willem G., Bondarenko Olga, Kok Wouter E. M., Götte Marco J. W., Boellaard Ronald, Beek Aernout M., Visser Cees A., van Rossum Albert C., Lammertsma Adriaan A., Visser Frans C. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET Journal of nuclear medicine 2005;46 (6):923-929 [PubMed]
• Wilde A. A. M., Kok W. E. M. Lang-QT-intervalsyndroom (LQTS)in: J. J. de Gier, H. C. S. van Buren, editors. Commentaren Medicatiebewaking 2005/2006. Houten: Stichting Health Base; 2005. p. 574-580

2001

• Kok W. E., Peters R. J., Pasterkamp G., van Liebergen R. A., Piek J. J., Koch K. T., Visser C. A. Early lumen diameter loss after percutaneous transluminal coronary angioplasty is related to coronary plaque burden: a role for viscous plaque properties in early lumen diameter loss international journal of cardiovascular imaging 2001;17 (2):111-121 [PubMed]

2000

• Kok W. E., Peters R. J., Pasterkamp G., di Mario C., Serruys P. W., Prins M. [=Martin H.], Visser C. A. Greater late lumen loss after successful coronary balloon angioplasty in the proximal left anterior descending coronary artery is not explained by extent of vessel wall damage or plaque burden Journal of the American College of Cardiology 2000;35 (2):382-388 [PubMed]
• Peters R. J., Kok W. E., Pasterkamp G., von Birgelen C., Prins M. [=Martin H.], Serruys P. W. Videodensitometric quantitative angiography after coronary balloon angioplasty, compared to edge-detection quantitative angiography and intracoronary ultrasound imaging European heart journal 2000;21 (8):654-661 [PubMed]

1999

• Kok W. E., Umans V. A., Arnold A. E. Transfer delay for primary PTCA: does it influence clinical outcome? Percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology 1999;33 (7):2087-2088 [PubMed]

1998

• Chamuleau S. A., Piek J. J., Hanekamp W. B., Appelman Y. E., Koch K. T., Peters R. J., Kok W. E., Bloemhard G., la Rivière G. A., David G. K. An analogue laser optical disc in comparison with cinefilm for visual analysis of coronary narrowings before and after coronary angioplasty International journal of cardiac imaging 1998;14 (1):19-26 [PubMed]
• de Winter R. J., Kok W. E., Piek J. J. Coronary atherosclerosis within a myocardial bridge, not a benign condition Heart (British Cardiac Society) 1998;80 (1):91-93 [PubMed]

1997

• Pasterkamp G., Peters R. J., Kok W. E., van Leeuwen T. G., Borst C. Arterial remodeling after balloon angioplasty of the coronary artery: an intravascular ultrasound study. PICTURE Investigators. PostTreatment IntraCoronary Transluminal Ultrasound Result Evaluation American heart journal 1997;134 (4):680-684 [PubMed]
• Peters R. J., Kok W. E., di Mario C., Serruys P. W., Bär F. W., Pasterkamp G., Borst C., Kamp O., Bronzwaer J. G., Visser C. A., Piek J. J., Panday R. N., Jaarsma W., Savalle L., Bom N. Prediction of restenosis after coronary balloon angioplasty. Results of PICTURE (Post-IntraCoronary Treatment Ultrasound Result Evaluation), a prospective multicenter intracoronary ultrasound imaging study Circulation 1997;95 (9):2254-2261 [PubMed]

1996

• Peters R. J., Kok W. E., van der Wal A. C., Visser C. A. Determinants of echodensity at the intima-media interface with intracoronary ultrasound imaging Journal of the American Society of Echocardiography 1996;9 (3):329-336 [PubMed]
• Peters R. J., Kok W. E., van der Wal A. C., Visser C. A. In vitro validation of intravascular ultrasound imaging after balloon angioplasty of coronary artery stenoses Ultrasound in medicine & biology 1996;22 (8):999-1005 [PubMed]
• Peters R. J., Kok W. E., Rijsterborgh H., van Dijk M., Koch K. T., Piek J. J., David G. K., Visser C. A. Reproducibility of quantitative measurements from intracoronary ultrasound images. Beat-to-beat variability and influence of the cardiac cycle European heart journal 1996;17 (10):1593-1599 [PubMed]

1995

• Kok W. E., Peters R. J., Prins M. H., Piek J. J., Koch K. T., David G. K., Visser C. A. Contribution of age and intimal lesion morphology to coronary artery wall mechanics in coronary artery disease Clinical science (London, England 1995;89 (3):239-246 [PubMed]

1994

• Peters R. J., Kok W. E., Bot H., Visser C. A. Characterization of plaque components with intracoronary ultrasound imaging: an in vitro quantitative study with videodensitometry Journal of the American Society of Echocardiography 1994;7 (6):616-623 [PubMed]
• Peters R. J., Kok W. E., Havenith M. G., Rijsterborgh H., van der Wal A. C., Visser C. A. Histopathologic validation of intracoronary ultrasound imaging Journal of the American Society of Echocardiography 1994;7 (3 Part 1):230-241 [PubMed]
• Borgdorff P., Kok W. E., Vis M. A., van den Bos G. C. Vasodilation by shear-induced platelet aggregation in extracorporeal circuits American journal of physiology 1994;266 (3 Part 2):H891-H897 [PubMed]

1992

• Borgdorff P., Kok W. E., van den Bos G. C. Extracorporeal circuits and autoregulation: effect of albumin coating American journal of physiology 1992;263 (5 Part 2):H1397-H1401 [PubMed]